15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Biodesix Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $26.00 to $32.00, so the covering firms are broadly aligned. The average target of $28.33 sits 30% above the current $21.86. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 4 over recent months. On the fundamentals, the Street sees revenue growth near 25% this year and 20% next, consensus EPS building from about $-0.79 next quarter toward $-1.77 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Biodesix Inc.
As of Jul, 4 of 4 firms rate BDSX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BDSX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.79
Range $-0.84 – $-0.74 · 7 analysts · -32% YoY
Next period, 7 analysts expect Biodesix Inc to earn $-0.79 a share (range $-0.84 – $-0.74), versus $-1.16 a year earlier. Full-year consensus is $-2.96, growing to $-1.77 the year after.
REVENUE · NEXT QUARTER
$27.6M
Range $27.4M – $28.1M · 7 analysts · +27% YoY
Revenue is expected to reach $27.6M (range $27.4M – $28.1M), +27.0% year-over-year. Full-year consensus is $111.0M, rising to $132.8M next year.
Top analysts covering Biodesix Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BDSX.
#1
KM
Kyle Mikson
Canaccord Genuity · Rank #192
Buy
$27.00+23.5% to target
Overall win rate
35%
+ Follow
#2
SJ
Sung Ji Nam
Scotiabank · Rank #196
Buy
$2.00-90.9% to target
Overall win rate
45%
+ Follow
#3
Yi Chen
HC Wainwright & Co. · Rank #238
Buy
$26.00+18.9% to target
Overall win rate
34%
+ Follow
#4
TF
Thomas Flaten
Lake Street
Buy
$40.00+83.0% to target
Coverage
—
+ Follow
#5
BW
Brian Weinstein
William Blair
Buy
No targeton BDSX
Coverage
—
+ Follow
BDSX stock forecast FAQ
What is BDSX's average 12-month price target?+
The 3 analysts with a live target average $28.33 for Biodesix Inc over the next 12 months, ranging from a $32.00 high to a $26.00 low.
Is BDSX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BDSX?+
The Street-high target is $32.00 (Roth Capital), and the Street-low is $26.00 (HC Wainwright & Co.). The average of all 3 active targets is $28.33.
How many Wall Street analysts cover BDSX?+
4 analysts have an active rating on Biodesix Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering BDSX?+
Among analysts who currently cover BDSX, Kyle Mikson of Canaccord Genuity has the strongest overall Quantellect track record (Rank #192). Their current call is Buy with a $27.00 target.
What is Biodesix Inc's projected EPS for next quarter?+
The consensus estimate is $-0.79 per share (range $-0.84 – $-0.74) across 7 analysts. Full-year EPS is projected at $-2.96, rising to $-1.77 the following year.
How much revenue is Biodesix Inc expected to report next quarter?+
Consensus revenue is $27.6M (range $27.4M – $28.1M). Full-year revenue is projected at $111.0M, growing to $132.8M next year.
Have analysts been upgrading or downgrading BDSX lately?+
As of Jul, 4 of 4 firms rate BDSX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BDSX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
